Advanced Biomed Inc Operating Expenses
Advanced Biomed Inc (ADVB) reported Operating Expenses of $519.84 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-05-15
- Advanced Biomed Inc operating expenses for the quarter ending 2026-03-31 was $519.84K, a 8.40% decline year-over-year.
- Advanced Biomed Inc operating expenses for the quarter ending 2025-12-31 was $396.64K, a 41.63% increase year-over-year.
- Advanced Biomed Inc operating expenses for the quarter ending 2025-09-30 was $523.91K, a 0.75% increase year-over-year.
- Advanced Biomed Inc operating expenses for the quarter ending 2025-06-30 was $1.95M, a 176.16% increase year-over-year.
- Advanced Biomed Inc operating expenses for fiscal 2025 was $3.02M, a 18.86% increase from fiscal 2024.
- Advanced Biomed Inc operating expenses for fiscal 2024 was $2.54M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $519.84K 10-Q · filed 2026-05-15 | $916.48K derived: sum of 2 quarters · filed 2026-05-15 | $1.31M 10-Q · filed 2026-05-15 | $3.39M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | $396.64K 10-Q · filed 2026-02-13 | $791.52K 10-Q · filed 2026-02-13 | $2.87M derived: sum of 3 quarters · filed 2026-02-13 | $3.43M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-09-30 | $523.91K 10-Q · filed 2025-11-19 | $2.47M derived: sum of 2 quarters · filed 2025-11-19 | $3.04M derived: sum of 3 quarters · filed 2026-05-15 | $3.32M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-06-30 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $2.51M derived: sum of 2 quarters · filed 2026-05-15 | $2.79M derived: sum of 3 quarters · filed 2026-05-15 | $3.02M 10-K · filed 2025-10-08 | |||
| 2025-03-31 | $567.51K 10-Q · filed 2026-05-15 | $762.74K 10-Q · filed 2025-05-15 | $847.57K derived: sum of 2 quarters · filed 2026-05-15 | $1.08M 10-Q · filed 2026-05-15 | $1.81M 10-Q · filed 2025-05-15 | $2.07M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $280.06K 10-Q · filed 2026-02-13 | $525.73K 10-Q · filed 2025-04-15 | $507.64K 10-Q · filed 2026-02-13 | $1.05M 10-Q · filed 2025-04-15 | $1.50M derived: sum of 3 quarters · filed 2026-02-13 | $2.25M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $520.03K 10-Q · filed 2025-11-19 | $1.22M derived: sum of 2 quarters · filed 2025-11-19 | $1.97M derived: sum of 3 quarters · filed 2025-11-19 | $2.62M derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | $704.61K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $1.45M derived: sum of 2 quarters · filed 2025-10-08 | $2.10M derived: sum of 3 quarters · filed 2025-10-08 | $2.54M 10-K · filed 2025-10-08 | |||
| 2024-03-31 | $745.41K 10-Q · filed 2025-05-15 | $1.40M derived: sum of 2 quarters · filed 2025-05-15 | $1.84M 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $651.30K 10-Q · filed 2025-04-15 | $1.09M 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |